Hypertension is characterized by endothelial dysfunction, vascular remodeling, and rearrangement of the extracellular matrix. Besides, the pathogenesis of hypertension is closely related to excess generation of reactive oxygen species (ROS). Nicotinamide phosphoribosyltransferase (NAMPT) is a rate-limiting enzyme in nicotinamide adenine dinucleotide (NAD) biosynthesis that influences the activity of NAD-dependent enzymes, such as sirtuins, which possess NAD-dependent protein deacetylase activity and cleave NAD during the deacetylation cycle. Recently, NAMPT has been shown to play a crucial role in various diseases associated with oxidative stress. However, the function and regulation of NAMPT in hypertension have not been extensively explored. In the present study, we identified NAMPT as a crucial regulator of hypertension, because NAMPT expression was significantly downregulated in both patients with hypertension and experimental animals. NAMPT knockout (NAMPT+/-) mice exhibited a significantly higher blood pressure and ROS levels after stimulation with angiotensin II (Ang II) than wild-type mice, and the administration of recombinant human NAMPT (rhNAMPT) reversed this effect. In vivo, overexpression of NAMPT protected against angiotensin II- (Ang II-) induced hypertension by inhibiting ROS production via sirtuin 1 in mouse aortic endothelial cells (MAECs) and mouse aortic vascular smooth muscle cells (MOVAs). In turn, NAMPT alleviated the ROS-induced mitogen-activated protein kinase (MAPK) pathway. In conclusion, NAMPT might be a novel biomarker and a therapeutic target in hypertension.
Esophageal squamous cell carcinoma (ESCC) is the most common and aggressive tumor worldwide, and the long-term survival of these patients remains poor. Three databases (GSE17351, GSE20347, and GSE100942) were obtained from Gene Expression Omnibus, and 193 differentially expressed genes including 56 upregulated and 137 downregulated genes were identified by paired test using limma R package. Then, functional enrichments by gene ontology and Kyoto Encyclopedia of Genes and Genomes analyses showed these genes were mainly related protein digestion and absorption, and IL-17 signaling pathway. We then constructed a protein-protein interaction network and cytoHubba module to determine the six hub genes and overall survival analysis of the six hub genes were evaluated by UALCAN and GEPIA2 analysis. Ultimately, the experimental results confirmed the KIF4A was overexpressed in the ESCC tissues and cell lines compared with the normal esophageal mucosal tissues and was linked to poor prognosis. Moreover, we also revealed that KIF4A facilitates proliferation, cell cycle, migration, and invasion of ESCC in vivo and in vitro. Overall, these findings demonstrated that KIF4A could serve as diagnostic and prognostic biomarkers and may help facilitate therapeutic targets in ESCC patients.
Esophageal cancer (ESCA) is the most common and aggressive tumor worldwide, and the long-term survival of ESCA patients remains poor. The competing endogenous RNAs (ceRNAs) hypothesis has been mostly applied in the study of molecular biological mechanisms of cancer occurrence and progression. However, studies on comprehensive analysis of lncRNA-miRNA-mRNA ceRNA prognostic regulatory network of ESCA based on high-throughput sequencing and the large-scale sample size is limited. Here, the expression profiles of lncRNAs and mRNAs were retrieved from both 555 Esophagus Mucosa (GTEx) as normal and 162 ESCA samples (TCGA). We applied the limma and edgeR packages to identify differentially expressed mRNAs and lncRNAs. We also applied the weighted gene co-expression network analysis (WGCNA) to identify differentially expressed pattern of mRNAs and lncRNAs. Then we further used MiRcode, starBase, miRTarBase, miRDB, and TargetScan to predict interactions between lncRNAs, miRNAs, and target mRNAs. Importantly, the 275 overlapped genes were analyzed by univariate and multivariate cox proportional hazard regression, and we set up a survival model for 5-year OS with 8 genes (SH3BP4+RUNX3+IGF2+COX20+TIAM2+BCAT1+NME2+HOXC8), of which the AUC was only 0.853 at 5th year. Finally, we constructed a ceRNA network including 99 lncRNAs, 4 miRNAs, and 6 mRNAs through these 8 genes. Consequently, these 6 hub genes might act as prognostic biomarkers and therapeutic targets of ESCA. Furthermore, BCAT1 may be involved in regulating immune cell infiltration and macrophage polarization, Ultimately, We verified that the expression of BCAT1 was significantly increased in Esophageal squamous cell carcinoma tissues, and its expression was correlated with DFS, which may provide new treatment strategies for ESCA.